Table 1 Demographic and clinical characteristics of evaluable subjects with and without PAD.

Weight (Kg)

76.5 ± 14

77.1 ± 14.3

Waist circumference (cm)

98 ± 12

97.9 ± 12.8

BMI (Kg/M²)

27.8 ± 4.3

27.8 ± 4.5

SBP (mmHg)

136.4 ± 14.6

141 ± 14.6

< 0.0001

DBP (mmHg)

81.6 ± 8.3

83 ± 8.2

< 0.0001

Heart rate (beats/min)

72.8 ± 8.7

74.2 ± 8.2

< 0.0001

   Age (years, mean ± SD)

63.9 ± 8.7

64.1 ± 9.2

Median

63

64

Interquartile range

58-70

58-70

   Age class (%)

45-54 years

11.4

12.8

55-64 years

44

41

65-74 years

32.3

32.1

75-84 years

11.2

12.2

≥85 years

1.1

1.9

0.039

   Sex

Male

50.4

51

Female

49.6

49

Race (%)

Caucasian

99.5

99.6

Black

0.1

0.1

Oriental

0

0

Other

0.4

0.3

   Marital status (%)

Single (unmarried)

4.9

4.5

Married or living together

79.7

68

< 0.0001

Widowed

11.4

13.5

Divorced or separated

3.9

13.9

< 0.0001

Other

0.1

0.1

   Anamnesis (%)

Hypertension

73.7

77.3

0.016

Dyslipidemia

45.2

37.6

< 0.0001

Cigarette smoking

30.2

25.2

0.0008

High alcohol intake

6.1

8.1

0.015

Family history of early CHD

17.4

41.8

< 0.0001

Sedentary lifestyle

64.7

61.2

   Serum lipids (mg/dl)

Total cholesterol

216.3 ± 39.2

216.9 ± 38.3

HDL-cholesterol

53.7 ± 13.4

51.9 ± 12.9

< 0.001

LDL-cholesterol

134.4 ± 35.4

134.8 ± 35.4

Triglycerides

138.6 ± 62.7

156.4 ± 70

< 0.0001

   Medication (%)

Antihypertensive

54.5

60.05

0.003

Other CV drug

7.23

5.82

Any lipid modifiers

18.18

14.29

0.002

Statin treatment

11.6

6.5

< 0.0001